Safety profile of COVID-19 vaccines, preventive strategies, and patient management-Reference-Cited by-同舟云学术

Safety profile of COVID-19 vaccines, preventive strategies, and patient management

Published:2022-05-19 Issue:8 Volume:21 Page:1087-1095
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Prabhu M. Mukhyaprana¹^ORCID,Palaian Subish²^ORCID,Ansari Mukhtar³^ORCID

Affiliation:

1. Department of General Medicine, KMC Manipal, MAHE (deemed to be University), India

2. Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, United Arab Emirates

3. Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Saudi Arabia

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2022.2078311

Reference84 articles.

1. World Health Organization. WHO coronavirus (COVID-19) dashboard. 2021 [Cited 2021 1 Jun]. Available from: https://covid19.who.int/.

2. Bergman SJ, Cennimo DJ, Miller MM, et al. COVID-19 treatment: investigational drugs and other therapies. Medscape; 2021 [Cited 2021 May 31]. Available from: https://emedicine.medscape.com/article/2500116-overview

3. Non-pharmacological treatments for COVID-19: current status and consensus

4. US Food and Drug Administration. Emergency use authorization (EUA) 2021[Cited 2021 May 30]. Available from: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#vaccines

5. World Health Organization. Status of COVID-19 vaccines within WHO EUL/PQ evaluation process. 2021 [Cited 2021 May 30]. Available from: https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_18May2021.pdf.